Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimum Dosage of Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery

NCT03095404 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03095404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03095404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimum Dosage of Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery
Lead sponsor
McMaster University
Phase
Phase 1
Overall status
Withdrawn
Start date
October 5, 2022
Completion date
August 26, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric bowel surgery, bariatric surgery candidate